MadhavThambisettyMDPhD

PubMed

• 12 citations
  Alzheimer's drugs: Does reducing amyloid work?
  Madhav Thambisetty, Robert Howard, M. Maria Glymour, Lon S. Schneider
  Science. 2021-10-29
• 534 citations
  Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte ...
  Erik C. B. Johnson, Eric B. Dammer, Duc M. Duong, Lingyan Ping, Maotian Zhou
  Nature Medicine. 2020-04-13
• 249 citations
  A multicentre validation study of the diagnostic value of plasma neurofilament light.
  Nicholas J. Ashton, Shorena Janelidze, Ahmad Al Khleifat, Antoine Leuzy, Emma L. van der Ende
  Nature Communications. 2021-06-07

Journal Articles

• Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.  
  Whiley L, Sen A, Heaton J et al., NEUROBIOLOGY OF AGING 35(2):271-8, 2014
• Pharmacologic inhibition of ROCK2 suppresses amyloid-ß production in an Alzheimer disease mouse model  
  Herskowitz JH, Feng, Higginbotham L et al., J NEUROSCIENCE 33(49):19086-98, 2013
• Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes.  
  Hales CM, Rees H, Seyfried NT et al., J NEUROPATHOL EXP NEUROL 72(11):1009-15, 2013
• Alzheimer disease risk genes and the age-at-onset phenotype.  
  Thambisetty M et al., NEUROBIOLOGY OF AGING 34(11) 2696.e1-5, 2013
• Impaired Glucose Tolerance in Midlife and Longitudinal Changes in Brain Function During Aging.  
  Thambisetty M et al., NEUROBIOLOGY OF AGING 34(10):2271-6, 2013
• Glucose intolerance, insulin resistance and Alzheimer’s disease pathology in the Baltimore Longitudinal Study of Aging.  
  Thambisetty M et al., JAMA NEUROLOGY 70(9): 1167-72, 2013
• Alzheimer risk variant clusterin (CLU) and brain function in aging.  
  Thambisetty M et al., BIOLOGICAL PSYCHIATRY 73(5):399-405, 2013
• The effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype  
  Thambisetty M et al., BIOLOGICAL PSYCHIATRY 73(5):422-8, 2013
• Processing and memory for emotional and neutral material in amyotrophic lateral sclerosis  
  Cuddy M, Papps BJ, Thambisetty M, et al., Amyotrophic Lateral Sclerosis. 13(6):592-8, 2012
• Plasma based markers of [11C] PiB-PET brain amyloid burden  
  Kiddle S, Thambisetty M et al., PLoS ONE 7(9):e44260, 2012
• Plasma biomarkers associated with ApoE genotype and Alzheimer's disease.  
  Soares H, Potter W, Pickering E et al., ARCHIVES OF NEUROLOGY 69(10):1310-7, 2012
• Baseline cardiovascular risk predicts subsequent changes in resting brain function.  
  Beason-Held L, Thambisetty M, Deib G et al., STROKE 43(6):1542- 1547, 2012
• The utility of 11C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.  
  Thambisetty M et al., JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 32(4):676-84,, 2012
• Join now to see all

Abstracts/Posters

• The Effect of CR1 on Brain Amyloid Burden during Aging and its Modification by APOE Genotype
  Thambisetty M, An Yang, Nalls M et al, 6th Human Amyloid Imaging meeting, Miami, FL, 1/1/2012
• Impaired glucose tolerance predicts longitudinal changes in brain function during aging in non- demented elderly
  Thambisetty M, Beason-Held L, An Y et al, 15th International Conference on Alzheimer’s Disease and Related Disorders, Vancouver, Canada, 1/1/2012
• Alzheimer’s risk variant clusterin (CLU) and brain function in aging
  Thambisetty M, Beason-Held L, Kraut M et al, 14th International Conference on Alzheimer’s Disease and Related Disorders, Paris, 1/1/2011
• Combinatorial, multimodal biomarkers from large variable datasets: findings from the Addneuromed study
  Lovestone S, Thambisetty M, Kronenberg D, et al, International Journal of Neuropsychopharmacology, 1/1/2010
• Clusterin Is a Plasma Biomarker of Severity, Progression and Pathology in Alzheimer's Disease
  Thambisetty M, Resnick SM, Ferrucci L, et al, 12th International Conference on Alzheimer’s Disease and Related Disorders, Vienna, 1/1/2009
• Proteomic Identification of Plasma Biomarkers for Hippocampal Atrophy in Alzheimer’s Disease
  Thambisetty M, Kinsey A, Hye A, et al, 11th International Conference on Alzheimer’s Disease and Related Disorders, Chicago, IL, 1/1/2008
• The Utility of 11C- Arachidonate PET to Study Human Dopaminergic Neurotransmission
  Thambisetty M, Liow J-S, Herscovitch P, et al, Society for Neuroscience, 1/1/2008
• Emotional memory and depression in ALS
  Cuddy M, Papps B, Thambisetty M, et al, Journal of Neurology, Neurosurgery and Psychiatry, 1/1/2007
• A Combined Proteomic and Neuroimaging Approach to Identifying Biomarkers in Alzheimer's Disease
  Madhav Thambisetty, Abdul Hye, Catherine Foy, et al, World Congress of Neurology, Sydney, Australia, 11/1/2005
• A novel 2-step diagnostic approach for RLS disease classification
  Rye DB, Bliwise D, Iranzo A, et al, 18th Annual Meeting of the Associated Professional Sleep Societies, 6/6/2004
• Involvement of lipoprotein receptor LR11 in Alzheimer’s disease and amyloid clearance
  Lah JJ, Offe K, Scherzer CR, et al, Soc. Neurosci. Abst, 1/1/2003
• Ataxic optic neuropathy
  Madhav TR, Scherzer CR, Yu Z, et al, Frank Walsh Society, North American Neuro-ophthalmology Society, 1/1/2001
• Antidepressant treatment and gene expression of brain derived neurotrophic factor (BDNF)
  Zetterstrom TS, Madhav TR, Coppell AL, et al, European Journal of Neuroscience, 1/1/2000
• Effect of 5-HT depletion on the dendritic spine density of granule cells in the adult rat hippocampus
  Madhav TR, Grahame-Smith DG, Zetterstrom TS, et al, Soc. Neurosci. Abst, 1/1/2000
• Evidence for the co-distribution of Trkb mRNA with serotonergic cell bodies in the rat raphe nucleus
  Zetterstrom TS, Madhav TR, Pei, Q, Fundamental and Clinical Phaemacology, 1/1/1999
• Manipulation of brain 5-HT levels affects gene expression for BDNF in rat brain
  Zetterstrom TS, Pei Q, Madhav TR, Grahame-Smith DG, British Journal of Pharmacology, 1/1/1998
• An in vivo model of serotoninergic axonal sprouting in the adult rat brain
  Madhav TR, Moorman JM, Leslie RA, Grahame-Smith DG, International School of Brain Research, 1/1/1997
• Join now to see all

Lectures

• APOE and partners in the post GWAS era: discovering biomarkers and understanding mechanisms in Alzheimer’s Disease 
  6/1/2013
• Is it memory loss or Alzheimer’s disease? Know the facts 
  5/1/2012
• Neuroimaging and Genetic Findings in Alzheimer’s Disease from the Baltimore Longitudinal Study of Aging 
  11/1/2011
• Clinical features, Diagnosis and Management of Alzheimer’s disease 
  1/1/2011
• Alzheimer’s disease: New Frontiers in Biomarkers and Therapeutics 
  11/1/2009
• Novel Approaches to Peripheral Biomarker Discovery in Alzheimer’s disease 
  11/1/2009
• Proteomic and Neuroimaging Approaches to Peripheral Biomarkers in Alzheimer’s disease 
  1/1/2007
• Novel Approaches to Peripheral Biomarkers in Alzheimer’s Disease 
  8/1/2006
• A Novel Approach to Peripheral Biomarkers in Alzheimer's Disease 
  Department of Biochemistry, National University of Singapore - 3/1/2006
• Genetic Testing and Counselling in Dementia 
  Athens, Greece - 9/1/2005
• Proteomic Approaches to Early Diagnosis of Alzheimer’s Disease 
  India - 5/1/2005
• Join now to see all